Search Within

Manuel Ramon De Jesus Escano

Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
Groups
  1. Sloan Kettering Institute Postdocs (12)
  2. Department of Medicine (11)
  3. Genitourinary Oncology Service (11)
  4. Solid Tumor Oncology Division (11)
  5. Surgery (11)
  6. Urology (11)

More Groups

People
  1. Bernard Bochner (11)
  2. David Solit (10)
  3. Eugene Pietzak (10)
  4. Gopakumar Iyer (10)
  5. Hikmat Al-Ahmadie (10)
  6. Alvin Goh (9)

More People

Years
  1. 2024 (5)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (2)
Publications
  1. Journal of Clinical Oncology (5)
  2. Urologic Oncology: Seminars and Original Investigations (4)
  3. Clinical Cancer Research (1)
  4. Cureus (1)
  5. JCO Precision Oncology (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. Elsevier Inc. (4)
  3. American Association for Cancer Research (1)
  4. Cureus Inc. (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Carcinoma in situ and urinary cytology as an indicator of minimal residual disease in patients with non-muscle invasive bladder cancer treated with BCG
    Meeting Abstract

    Katims, A. B.; D'Souza, N.; De Jesus Escaño, M. R.; Gokturk, G.; Basar, M.; Solit, D. B.; Iyer, G.; Bochner, B. H.; Goh, A.; Donahue, T. A.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Comutational patterns in FGFR3-altered non-muscle invasive bladder cancer influence recurrence and progression
    Meeting Abstract

    D'Souza, N.; de Jesus Escano, M.; Alam, S. M.; Gao, S.; Tang, X.; Goh, A.; Bochner, B. H.; Solit, D.; Iyer, G.; Al-Ahmadie, H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non–muscle-invasive bladder cancer (NMIBC)
    Meeting Abstract

    Dsouza, N.; Gaffney, C.; Hernandez, C.; Moran, P.; Worth, K.; McCarter, M.; de Jesus, M. R.; Solit, D. B.; Sarungbam, J.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Response Evaluation Criteria in Tumors of the Bladder (RECIT-Bladder) for future window of opportunity trials as a platform to accelerate drug development
    Meeting Abstract

    Gaffney, C.; Jiang, S.; de Jesus, M. R.; Chu, C. E.; Benfante, N.; Bajorin, D. F.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management
    Meeting Abstract

    Truong, H.; Sheikh, R.; Kemel, Y.; De Jesus Escano, M.; Khurram, A.; Reisz, P.; Lenis, A. T.; Goh, A. C.; Cha, E. K.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma
    Meeting Abstract

    Chu, C. E.; De Jesus Escano, M.; Yip, W.; Jiang, S.; Iyer, G.; Al-Ahmadie, H. A.; Goh, A. C.; Dalbagni, G.; Bochner, B. H.; Solit, D. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save